NovoCure Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

BMV:NVCR N Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
02 Nov 24	SellMex$14,734	Mukund Paravasthu	Individual	44	Mex$334.86
01 Nov 24	SellMex$191,267	Frank Leonard	Individual	598	Mex$319.84
01 Nov 24	SellMex$50,982	Mukund Paravasthu	Individual	160	Mex$318.64
31 Oct 24	SellMex$256,407	Michael Puri	Individual	810	Mex$316.55
02 Aug 24	SellMex$264,185	Ashley Cordova	Individual	688	Mex$383.99
04 Jun 24	SellMex$408,823	Timothy Scannell	Individual	964	Mex$424.09
04 Jun 24	SellMex$408,783	Kinyip Leung	Individual	964	Mex$424.05
04 Jun 24	SellMex$408,918	William Vernon	Individual	964	Mex$424.19
04 Mar 24	SellMex$684,900	Frank Leonard	Individual	2,519	Mex$271.99
04 Mar 24	SellMex$903,743	Wilhelmus C. Groenhuysen	Individual	3,324	Mex$271.99
28 Feb 24	SellMex$635,710	Wilhelmus C. Groenhuysen	Individual	2,303	Mex$276.04
28 Feb 24	SellMex$573,602	Frank Leonard	Individual	2,078	Mex$276.04

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of NVCR N?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	3,823	0.00358%
State or Government	46,084	0.0431%
General Public	4,069,162	3.81%
Individual Insiders	11,178,352	10.5%
Institutions	91,563,692	85.7%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 82.43% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
16.8%	Capital Research and Management Company	17,903,630	Mex$4.5b	-12.5%	0.01%
14.9%	FMR LLC	15,957,802	Mex$4.0b	0.21%	0.02%
9.15%	Hansjoerg Wyss	9,780,397	Mex$2.5b	0%	no data
9.02%	The Vanguard Group, Inc.	9,636,993	Mex$2.4b	-0.28%	no data
7.36%	BlackRock, Inc.	7,862,381	Mex$2.0b	-3.18%	no data
4.77%	Baillie Gifford & Co.	5,095,777	Mex$1.3b	-25.2%	0.03%
2.34%	Deep Track Capital, LP	2,500,000	Mex$633.8m	0%	1.11%
2.21%	T. Rowe Price Group, Inc.	2,364,459	Mex$599.4m	-46.7%	no data
1.96%	State Street Global Advisors, Inc.	2,092,622	Mex$530.5m	-15.2%	no data
1.6%	Voloridge Investment Management, LLC	1,706,588	Mex$432.6m	668%	0.1%
1.42%	Nordwand Advisors, LLC	1,515,000	Mex$384.1m	0%	3.95%
1.41%	Geode Capital Management, LLC	1,504,991	Mex$381.5m	3.04%	no data
1.04%	Balyasny Asset Management L.P.	1,109,615	Mex$281.3m	29.2%	0.04%
0.89%	Norges Bank Investment Management	948,843	Mex$240.5m	0%	no data
0.86%	Two Sigma Advisers, LP	922,400	Mex$233.8m	1,210%	0.03%
0.83%	Coatue Management, L.L.C.	885,675	Mex$224.5m	0%	0.05%
0.8%	Point72 Asset Management, L.P.	859,581	Mex$217.9m	1,870%	0.03%
0.79%	Two Sigma Investments, LP	846,565	Mex$214.6m	2,450%	0.03%
0.75%	Credit Suisse Asset Management (Switzerland) Ltd.	796,679	Mex$202.0m	0.56%	0.01%
0.65%	Millennium Management LLC	692,949	Mex$175.7m	1,450%	0.01%
0.64%	Morgan Stanley, Investment Banking and Brokerage Investments	679,597	Mex$172.3m	2.81%	no data
0.63%	Citadel Advisors LLC	671,011	Mex$170.1m	21.6%	0.01%
0.62%	Palo Alto Investors LP	660,275	Mex$167.4m	14.2%	0.82%
0.52%	William Doyle	551,176	Mex$139.7m	0%	no data
0.51%	Jane Street Group, LLC, Asset Management Arm	545,091	Mex$138.2m	3.29%	0.01%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2023/12/30 07:56
End of Day Share Price	2023/10/02 00:00
Earnings	2023/09/30
Annual Earnings	2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

NovoCure Limited is covered by 14 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Gregory Gilbert	Deutsche Bank
Vijay Kumar	Evercore ISI
Emily Bodnar	H.C. Wainwright & Co.